Abstract
The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
Full Text
What is claimed is:
The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
Timeline
Filed
02/25/2026Published
06/25/2026Granted
Not AvailableIPC Codes(3)
A61K 35/74:Bacteria (therapeutic use of a bacterial protein A61K 38/00)
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 35/741:Probiotics (probiotic yeast, e.g. saccharomyces A61K 36/06)